Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04653428

German Registry for Transcatheter Tricuspid Valve Interventions

Status
Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
LMU Klinikum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multicentre observational study of patients with severe tricuspid regurgitation and interventional treatment.

Detailed description

Severe tricuspid regurgitation occurs in around 1.5 % of men and 5.6 % of women and it is associated with significant morbidity and mortality. Current guidelines recommend cardiac surgery, especially in those patients who are undergoing left side valve surgery. Nevertheless many patients are not eligible for surgical tricuspid valve repair due to an high risk of mortality. Therefore interventional devices for treatment of tricuspid regurgitation have been established to offer these patients an alternative treatment option. The aim of this study is to analyse the success and saftey aspects of different interventional repair techniques for severe tricuspid regurgitation. Therefore in this prospectively designed observational study clinical, echocardiographic and laboratory parameters will be collected.

Conditions

Interventions

TypeNameDescription
DEVICEInterventional treatment of tricuspid regurgitationInterventional treatment for tricuspid regurgitatin with CE-certified products, e.g. edge-to-edge repair

Timeline

Start date
2020-10-01
Primary completion
2025-12-31
Completion
2030-12-31
First posted
2020-12-04
Last updated
2020-12-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04653428. Inclusion in this directory is not an endorsement.